Modified orbicularis myotomy for the treatment of idiopathic blephatospasm

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045771

Enrollment

Unknown

Registered

2021-04-24

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic blephatospasm

Interventions

Experimental group:Surgery

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.The patient was diagnosed as idiopathic blepharospasm, who did not respond to botulinum toxin treatment. The patient was 40-80 years old; 2.Understand the effects of surgery and possible complications.

Exclusion criteria

Exclusion criteria: With serious systemic disease or mental disease, can not tolerate surgery.

Design outcomes

Primary

Measure	Time frame
amelioration of symptom;	—

Countries

China

Contacts

Public ContactLi Qingji

Tianjin Aier Eye Hospital

liqingji@sina.com+86 13920518915

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026